Stéphane DE LOMBAERT,Daniel R. GOLDBERG,Kenneth BRAMELD,Eric Brian SJOGREN,Andrew SCRIBNER
申请号：
HK16113946.0
公开号：
HK1225720A
申请日:
2016.12.07
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.
